Document is current
Any future updates will be listed below
-
Authors
Bryant, Dean https://orcid.org/0000-0003-3163-608X
Smith, Lindsay
Rogers-Broadway, Karly Rai
Karydis, Laura
Woo, Jeongmin
Blunt, Matthew D. https://orcid.org/0000-0003-1099-3985
Forconi, Francesco https://orcid.org/0000-0002-2211-1831
Stevenson, Freda K. https://orcid.org/0000-0002-0933-5021
Goodnow, Christopher
Russell, Amanda https://orcid.org/0000-0001-7148-1081
Humburg, Peter https://orcid.org/0000-0002-3331-6496
Packham, Graham
Steele, Andrew J.
Strefford, Jonathan C. https://orcid.org/0000-0002-0972-2881
- License Information
-
More Information
Article History
Received: 28 October 2022
Revised: 19 April 2023
Accepted: 21 April 2023
First Online: 11 May 2023
Competing interests
: FF declares the following competing interests: Honoraria: Abbvie, Janssen-cilag, Beigene, Astra-Zeneca; Speakers bureau: Abbvie, Janssen-cilag, Beigene, Astra-Zeneca Travel. JS declares the following competing interests: Research funding: Roche Holding AG and Cambridge Epigenetix. AJS declares the following competing interests: Current employee of Janssen Pharmaceutical Companies of Johnson and Johnson. All other authors declare no competing interests.
